Antifungal Resistance Trends of Candida auris Clinical Isolates in New York and New Jersey from 2016 to 2020

被引:34
|
作者
Kilburn, Shannon [1 ]
Innes, Gabriel [2 ]
Quinn, Monica [1 ]
Southwick, Karen [3 ]
Ostrowsky, Belinda [4 ]
Greenko, Jane A. [5 ]
Lutterloh, Emily [1 ,6 ]
Greeley, Rebecca [2 ]
Magleby, Reed [2 ]
Chaturvedi, Vishnu [1 ]
Chaturvedi, Sudha [1 ,6 ]
机构
[1] New York State Dept Hlth, Albany, NY 12202 USA
[2] New Jersey Dept Hlth, Trenton, NJ USA
[3] New York State Dept Hlth, New Rochelle, NY USA
[4] CDC, Ctr Dis Control & Prevent, Atlanta, GA 30333 USA
[5] New York State Dept Hlth, Cent Islip, NY USA
[6] State Univ Albany Sch Publ Hlth, Albany, NY 12222 USA
关键词
antifungals; Candida auris; minimum inhibitory concentration; epidemiological cutoff;
D O I
10.1128/aac.02242-21
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
About 55% of U.S. Candida auris clinical cases were reported from New York and New Jersey from 2016 through 2020. Nearly all New York-New Jersey clinical isolates (99.8%) were fluconazole resistant, and 50% were amphotericin B resistant. Echinocandin resistance increased from 0% to 4% and pan-resistance increased from 0 to C. auris clinical isolates but not for New Jersey, highlighting the regional differences. About 55% of U.S. Candida auris clinical cases were reported from New York and New Jersey from 2016 through 2020. Nearly all New York-New Jersey clinical isolates (99.8%) were fluconazole resistant, and 50% were amphotericin B resistant. Echinocandin resistance increased from 0% to 4% and pan-resistance increased from 0 to C. auris clinical isolates but not for New Jersey, highlighting the regional differences.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Candida auris Isolates Resistant to Three Classes of Antifungal Medications - New York, 2019
    Ostrowsky, Belinda
    Greenko, Jane
    Adams, Eleanor
    Quinn, Monica
    O'Brien, Brittany
    Chaturvedi, Vishnu
    Berkow, Elizabeth
    Vallabhaneni, Snigdha
    Forsberg, Kaitlin
    Chaturvedi, Sudha
    Lutterloh, Emily
    Blog, Debra
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2020, 69 (01): : 6 - 9
  • [2] Candida auris in New York
    Kazi, Farooq
    Mushtaq, Ammara
    LANCET INFECTIOUS DISEASES, 2020, 20 (03): : 294 - 294
  • [3] Simulating a travel-related origin of Candida auris in New York-New Jersey
    Verma, Rita R.
    Kiegle, Edward
    Keyel, Alexander C.
    Chaturvedi, Sudha
    Chaturvedi, Vishnu
    MICROBIOLOGY SPECTRUM, 2025, 13 (02)
  • [4] In Vitro Evaluation of Antifungal Drug Combinations against Multidrug-Resistant Candida auris Isolates from New York Outbreak
    O'Brien, Brittany
    Chaturvedi, Sudha
    Chaturvedi, Vishnu
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (04)
  • [5] In Vitro Antifungal Resistance of Candida auris Isolates from Bloodstream Infections, South Africa
    Maphanga, Tsidiso G.
    Naicker, Serisha D.
    Kwenda, Stanford
    Munoz, Jose F.
    van Schalkwyk, Erika
    Wadula, Jeannette
    Nana, Trusha
    Ismail, Arshad
    Coetzee, Jennifer
    Govind, Chetna
    Mtshali, Phillip S.
    Mpembe, Ruth S.
    Govender, Nelesh P.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (09)
  • [6] Pan-resistant Candida auris: New York subcluster susceptible to antifungal combinations
    O'Brien, Brittany
    Liang, Jiali
    Chaturvedi, Sudha
    Jacobs, Jonathan L.
    Chaturvedi, Vishnu
    LANCET MICROBE, 2020, 1 (05): : E193 - E194
  • [7] Candida auris Clinical Isolates from South Korea: Identification, Antifungal Susceptibility, and Genotyping
    Kwon, Yong Jun
    Shin, Jong Hee
    Byun, Seung A.
    Choi, Min Ji
    Won, Eun Leong
    Lee, Dain
    Lee, Seung Yeob
    Chun, Sejong
    Lee, Jun Hyung
    Choi, Hyun Jung
    Kee, Seung Jung
    Kim, Soo Hyun
    Shin, Myung Geun
    JOURNAL OF CLINICAL MICROBIOLOGY, 2019, 57 (04)
  • [8] Comparative genomics and antifungal susceptibility testing of clinical Candida auris isolates
    Herz, M.
    Barber, A. E.
    Ebner, S.
    Aldejohann, A. M.
    Walther, G.
    Martin, R.
    Kurzai, O.
    MYCOSES, 2021, 64 : 18 - 18
  • [9] Laboratory Analysis of an Outbreak of Candida auris in New York from 2016 to 2018: Impact and Lessons Learned
    Zhu, YanChun
    O'Brien, Brittany
    Leach, Lynn
    Clarke, Alexandra
    Bates, Marian
    Adams, Eleanor
    Ostrowsky, Belinda
    Quinn, Monica
    Dufort, Elizabeth
    Southwick, Karen
    Erazo, Richard
    Haley, Valerie B.
    Bucher, Coralie
    Chaturvedi, Vishnu
    Limberger, Ronald J.
    Blog, Debra
    Lutterloh, Emily
    Chaturvedi, Sudha
    JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (04)
  • [10] Antifungal drug susceptibility of Candida auris isolates from German hospitals
    Martin, R.
    Ebner, S.
    Hamprecht, A.
    Walther, G.
    Wagener, J.
    Kurzai, O.
    MYCOSES, 2018, 61 : 34 - 35